Daniel Solove writes: A recent article in The Atlantic discusses the risk of 23andMe selling its vast stockpile of DNA data on 15 million individuals: 23andMe is not doing well. Its stock is on the verge of being delisted. It shut down its in-house drug-development unit last month, only the latest in several rounds of layoffs. Last week,…
Category: Laws
Women’s Health on the Ballot in November: What the Election Could Mean for Reproductive Care and Beyond
Amanda Zablocki, Elizabeth A. Nevins, Arushi Pandya, and Krysten Thomas of SheppardMullin write: Over two years into the post-Dobbs era, women’s health is taking center stage in the presidential election. In Dobbs v. Jackson, the Supreme Court overturned protections relating to abortion established in Roe v. Wade. Since then, approximately half of the states across the country have enacted…
AB 2013: New California AI Law Mandates Disclosure of GenAI Training Data
Marc S. Martin and Sydney Veatch of Perkins Coie write: In the last 30 days, California Governor Gavin Newsom signed 17 artificial intelligence (AI) bills and vetoed AI safety bill SB 1047. One of the AI-related bills signed into law, AB 2013 “Generative Artificial Intelligence: Training Data Transparency,” imposes new disclosure requirements on the developers of…
China Issues Guideline on Sensitive Personal Information
Hunton Andrews Kurth writes: On September 18, 2024, the National Technical Committee 260 on Cybersecurity Standardization Administration of China released the “Cybersecurity Standard Practice Guideline – Sensitive Personal Information Identification Guideline” (the “Guideline”). Prior to this Guideline, existing laws of China, such as the Personal Information Protection Law and the Information Security Technology – Personal…